Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Why is Alnylam Pharmaceuticals stock surging today? - Investing.com

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty - Yahoo Finance

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - Yahoo! Finance Canada

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Is Agios Pharmaceuticals (AGIO) A Bargain After FDA Priority Review For Mitapivat? - Yahoo Finance Singapore

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Lobbying Update: $60,000 of VERTEX PHARMACEUTICALS INCORPORATED lobbying was just disclosed - Quiver Quantitative

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

FDA Approves Ennumo | PharmExec - Pharmaceutical Executive

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Upside Already Priced In? - Yahoo Finance

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Ionis Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $97.43, Implies 15% Upside - TradingView

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Tarsus Pharmaceuticals Acquires iRenix for $75M - Orange County Business Journal

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? - The Globe and Mail

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Lupin Pharmaceuticals is recalling 2.5 million bottles of prescription steroid eye drops over contamination - qz.com

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

MacroGenics Completes $122.5 Million Sale Of GMP Manufacturing Operations To Bora Pharmaceuticals - Pulse 2.0

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

S&P 500 Futures Climb in Premarket Trading; Alnylam Pharmaceuticals, BridgeBio Pharma Lead - Barron's

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) - Morningstar

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? - The Motley Fool

news.google.com · 10 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Why is Alnylam Pharmaceuticals stock surging today? - Investing.com

Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty - Yahoo Finance

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - Yahoo! Finance Canada

Is Agios Pharmaceuticals (AGIO) A Bargain After FDA Priority Review For Mitapivat? - Yahoo Finance Singapore

Lobbying Update: $60,000 of VERTEX PHARMACEUTICALS INCORPORATED lobbying was just disclosed - Quiver Quantitative

FDA Approves Ennumo | PharmExec - Pharmaceutical Executive

Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Upside Already Priced In? - Yahoo Finance

Ionis Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $97.43, Implies 15% Upside - TradingView

Tarsus Pharmaceuticals Acquires iRenix for $75M - Orange County Business Journal

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? - The Globe and Mail

Lupin Pharmaceuticals is recalling 2.5 million bottles of prescription steroid eye drops over contamination - qz.com

MacroGenics Completes $122.5 Million Sale Of GMP Manufacturing Operations To Bora Pharmaceuticals - Pulse 2.0

S&P 500 Futures Climb in Premarket Trading; Alnylam Pharmaceuticals, BridgeBio Pharma Lead - Barron's

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) - Morningstar

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? - The Motley Fool